F500-2020-140-Gilead-Sciences
Gilead Sciences/AP Images

Company Information

As of 6/5/23
Country
U.S.
Headquarters
Foster City, Calif.
Industry
Pharmaceuticals
CEO
Daniel P. O'Day
Company Type
Public
Ticker
GILD
Revenues ($M)
$27,281
Profits ($M)
$4,592
Market Value ($M)
$103,614
Employees
17,000
Market value as of March 31, 2023.

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$27,305
10.6%
Profits ($M)
$6,225
4961%
Assets ($M)
$67,952
-
Total Stockholder Equity ($M)
$21,069
-

Profit Ratios

Profit as % of Revenues
22.8%
Profits as % of Assets
9.2%
Profits as % of Stockholder Equity
29.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
4.93
EPS % Change (from 2020)
4830%
EPS % Change (5 year annual rate)
-13.1%
EPS % Change (10 year annual rate)
10.8%

Total Return

Total Return to Investors (2021)
29.8%
Total Return to Investors (5 year, annualized)
4%
Total Return to Investors (10 year, annualized)
16%

Gilead Sciences Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$24,68910%$123-97.7%$68,407$18,202
2020$22,4491.5%$5,386-1.3%$61,627$22,525
2019$22,127-15.2%$5,45517.9%$63,675$21,387
2018$26,107-14.1%$4,628-65.7%$70,283$20,442
2017$30,390-6.9%$13,501-25.4%$56,977$18,887
SHOW MORE
FortuneFortuneAnalytics tout
Lists ranking Gilead Sciences
RANK129
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE